Clinical Trial Update: A Study of the Efficacy and Safety of Carbidopa-Levodopa Extended-Release Tablets in Patients With Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update on the efficacy and safety of carbidopa-levodopa extended-release tablets in Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Carbidopa-levodopa Extended-Release Tablets (carbidopa-levodopa extended-release)

Snippet

Sponsor: Shanghai WD Pharmaceutical Co., Ltd. | Conditions: Parkinson Disease | Phase 2 | Status: UNKNOWN